Request a Quote
Leave Your Message
Premium Export Partner

Biosafety Cabinet Product & Exporter serving South Korea

Delivering advanced containment systems and aerosol inhalation toxicology solutions to South Korea's leading biopharmaceutical clusters, academic institutions, and GLP laboratories.

Featured Biosafety Containment Systems for South Korea

Engineered to meet stringent safety standards, our flagship nose-only exposure and containment platforms provide unparalleled protection and precision for preclinical research across South Korea's bio-valleys.

South Korea's Bio-Convergence Era & Containment Requirements

South Korea has rapidly emerged as a global epicentre for biomedical innovation, driven by government initiatives such as the "3rd Science and Technology Basic Plan" and massive private sector investments. Major biotech hubs like the Songdo Bio Cluster in Incheon, the Osong Bio Valley in Chungcheongbuk-do, and the research institutes of Daedeok Innopolis in Daejeon require state-of-the-art laboratory infrastructure. The demand for advanced Biosafety Cabinets and high-containment aerosol exposure systems is surging as South Korea expands its capabilities in vaccine development, cell therapies, and inhalation toxicology.

With the Ministry of Food and Drug Safety (MFDS) and the Korea Occupational Safety and Health Agency (KOSHA) enforcing stringent regulatory frameworks, local laboratories must adhere to uncompromising safety standards. Biosafety Cabinets and containment systems are no longer just standard laboratory furniture; they are critical barriers that prevent cross-contamination, protect lab technicians from hazardous biological agents, and guarantee the integrity of sensitive scientific data.

Songdo Bio Cluster Compliant MFDS GLP Standards KOSHA Safety Alignment Class II & III Biosafety
Advanced Biosafety Containment Infrastructure

Integrated Bio-Systems

Tailored engineering for South Korean biopharmaceutical laboratories.

Company Profile

Beijing HuirongheTechnology Co., Ltd., (overseas brand "HRHINS") founded in 2010 with a registered capital of 10 million yuan, is located in the Beijing Economic-Technological Development Area. The company specializes in the R&D, production, sales, and technical services for inhalation toxicity, genetic toxicity, inhaler testing, aerosol detection, and lab automation systems.

HRHINS has been recognized as a National High-tech Enterprise and designated as a Beijing Municipal Corporate Science and Technology R&D Institution. Additionally, it has received honors such as being a Beijing "Specialized, Refined, Unique, and Innovative" SME, a China Manufacturing Champion Enterprise, and a Beijing Intellectual Property Demonstration Enterprise.

Further accolades include being named a National Intellectual Property Advantage Enterprise in 2019, a National "Little Giant" SME (the first in the aerosol scientific instrument field) in 2022, and a recipient of the Second Prize in Scientific and Technological Progress from the Tianjin Municipal Government in 2022.

2010
Established in
3000m²
Office & R&D Facilities
60+
Instrument Developments
45+
Patents Secured

Why Choose Us

The company occupies over 3000sqm of offices, R&D center and workshops. We provide unparalleled containment technology backed by international certifications.

Certifications Icon

Certifications

HRHINS holds certifications for the ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, ISO 45001:2018 Occupational Health and Safety Management System, and GB/T 29490-2013 Intellectual Property Management System.

Founding Sponsor Icon

Founding Sponsor

In 2018, HRHINS supported the establishment of the Respiratory Toxicology Committee of the Chinese Society of Toxicology and became its founding sponsor. That same year, the company also gained council membership in several prestigious organizations, including the Chinese Society of Toxicology, the Chinese Environmental Mutagen Society, and the Zhongguancun New Bio-pharmaceutical Industry Alliance.

Biosafety & Inhalation Toxicology Trends in South Korea

As South Korea pivots towards advanced biological therapeutics and environmental safety assessments, the containment and aerosol research industry is experiencing rapid evolution.

1. GLP Laboratory Expansion

South Korea's toxicological evaluation standards are aligning closely with OECD guidelines. Laboratories conducting Good Laboratory Practice (GLP) toxicology studies require precise, repeatable exposure chambers and biosafety cabinets that minimize variable factors while ensuring zero aerosol leaks.

2. Inhalation Drug Delivery

With the rise of pulmonary drug delivery systems for treating chronic respiratory conditions and systemic diseases, researchers in Seoul and Gyeonggi-do rely on nose-only exposure systems. These systems deliver precise micro-doses of therapeutic aerosols directly to subjects under high-containment biosafety conditions.

3. Smart Automation & IoT

South Korean labs are highly digitized. The integration of real-time particle counters, digital airflow sensors, and automated negative pressure controls within biosafety cabinets allows researchers to monitor containment parameters remotely, ensuring absolute safety for both personnel and samples.

Biosafety Solutions for South Korea

Localized Application Scenarios in South Korea

Our biosafety containment systems and inhalation toxicology instruments are designed to address the specific needs of various high-tech industries in South Korea:

  • Biopharmaceutical R&D (Incheon & Osong): Facilitating safe preclinical research on monoclonal antibodies, biosimilars, and mRNA vaccines where containment of aerosolized pathogens is non-negotiable.
  • Environmental Health Studies (KIST & National Universities): Evaluating the toxicity of atmospheric fine dust (PM2.5), nano-particles, and chemical inhalants prevalent in industrial zones.
  • Infectious Disease Research (Korea Disease Control and Prevention Agency - KDCA): Providing secure, negative-pressure containment enclosures for handling airborne pathogens and conducting vaccine efficacy trials.
  • Agricultural Chemistry Safety: Testing inhalation safety profiles of agricultural pesticides and fertilizers to comply with South Korea's strict chemical safety registries (K-REACH).

Comprehensive Aerosol & Containment Solutions

HRHINS offers an extensive array of advanced tools designed to meet the rigorous demands of modern toxicology and biosafety containment.

HRHINS has developed over 60 innovative instruments, including aerosol generators, inhalation systems, fully automated QuEChERS system, multi-stage cascade impactor, and breathing simulator, etc.

The aerosol toxicity instrument line offers a complete suite for studies involving rats, mice, guinea pigs, ferrets, rabbits, dogs, and monkeys. Supported exposure methods are equally comprehensive, covering nose-head, whole-body, airborne infection, and in vitro cell culture exposures.

Crucially, all products—from aerosol generation and detection to sampling and system control—are based on independent intellectual property.

These solutions are widely employed by GLP laboratories, safety assessment centers, universities, research institutions, and hospital respiratory departments. Thanks to their superior quality and reliable after-sales support, our products have earned the trust of users both in China and internationally.

Seamless Export & Dedicated Support for South Korea

As a trusted supplier to South Korea's advanced biotech sectors, HRHINS ensures a seamless procurement and integration experience.

Our export operations are optimized for rapid delivery to major scientific hubs, including Incheon, Seoul, Daejeon, and Daegu. We provide comprehensive customs documentation, compliance verification with local safety authorities, and specialized protective packaging to ensure your equipment arrives in pristine condition.

Beyond delivery, HRHINS offers dedicated technical support, remote validation guidance, and a robust warranty program. We work closely with local laboratory engineers and safety officers to ensure all containment systems are calibrated precisely to your specific research protocols, maintaining compliance with both domestic and international biosafety standards.